Neuromodulation techniques for status epilepticus: A review

被引:20
作者
San-juan, Daniel [1 ]
Oswaldo Davila-Rodriguez, Daniel [1 ]
Ramos Jimenez, Christian [2 ]
Sanchez Gonzalez, Manuel [3 ]
Mayorquin Carranza, Sergio [4 ]
Hernandez Mendoza, Jesus Ricardo [5 ]
Anschel, David J. [6 ]
机构
[1] Natl Inst Neurol & Neurosurg Manuel Velasco Suare, Dept Neurophysiol, Mexico City, DF, Mexico
[2] Autonomous Univ State Mexico, Fac Med, Toluca De Lerdo, State Of Mexico, Mexico
[3] Univ Guadalajara, Fac Med, Guadalajara, Jalisco, Mexico
[4] Autonomous Univ Nayarit, Acad Unit Med, Tepic, Nayarit, Mexico
[5] Autonomous Univ Baja California, Fac Med Mexicali, Mexicali, Baja California, Mexico
[6] Comprehens Epilepsy Ctr Long Isl, Port Jefferson, NY USA
关键词
Electroconvulsive therapy; Vagal nerve stimulation; Transcranial magnetic stimulation; Deep brain stimulation; Status epilepticus; Refractory status epilepticus; TRANSCRANIAL MAGNETIC STIMULATION; REFRACTORY STATUS EPILEPTICUS; VAGAL NERVE-STIMULATION; DEEP BRAIN-STIMULATION; ELECTROCONVULSIVE-THERAPY; ELECTRICAL-STIMULATION; POTENTIAL MECHANISMS; 1ST EPISODE; MORTALITY; SEIZURES;
D O I
10.1016/j.brs.2019.04.005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Electroconvulsive therapy (ECT), Vagal Nerve Stimulation (VNS), Transcranial Magnetic Stimulation (TMS) and Deep Brain Stimulation (DBS) are neuromodulation therapies that have been used to treat Status Epilepticus (SE). Objective: Review the literature about the efficacy and safety of neuromodulation therapies in SE in humans. Methods: We searched studies in PubMed, Scopus, Google Scholar and Science Direct (inception to June 2018). Four review authors independently selected the studies, extracted data and assessed the methodological quality of the studies using the recommendations of the Cochrane Handbook for Systematic Reviews of Interventions, PRISMA guidelines, Oxford and GRADE scales, and Murad et al., 2018 methodological quality and synthesis of case series and case reports. Results: We analyzed 27 articles (45 patients) with 4 different neuromodulation therapies. In ECT we found 80% rate of disruption of SE and 5% of adverse events was reported. Using iVNS 15/16 (93.7%) patients resolved the SE. All patients who underwent TMS and DBS aborted SE, however, 50% of patients with DBS had severe adverse events. Conclusions: Case series and case reports suggest that neuromodulation therapies can abort SE in 80-100% of patients (Oxford scale and GRADE were level 4 and D) with a wide range of adverse effects, which claims for prospective studies on the relationship be-tween efficacy and safety. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码:835 / 844
页数:10
相关论文
共 83 条
[1]   The vagal nerve stimulation outcome, and laryngeal effect: Otolaryngologists roles and perspective [J].
Al Omani, Ahmad I. ;
Alzoubi, Firas Q. ;
Alsalem, Mohammad M. ;
Aburahma, Samah K. ;
Mardini, Diala T. ;
Castellanos, Paul F. .
AMERICAN JOURNAL OF OTOLARYNGOLOGY, 2017, 38 (04) :408-413
[2]   Neurocritical Care: Status Epilepticus Review [J].
Al-Mufti, Fawaz ;
Claassen, Jan .
CRITICAL CARE CLINICS, 2014, 30 (04) :751-+
[3]   Neuromodulation in Epilepsy [J].
Al-Otaibi, Faisal A. ;
Hamani, Clement ;
Lozano, Andres M. .
NEUROSURGERY, 2011, 69 (04) :957-979
[4]   Transcranial magnetic stimulation: Neurophysiological applications and safety [J].
Anand, S ;
Hotson, J .
BRAIN AND COGNITION, 2002, 50 (03) :366-386
[5]  
[Anonymous], DEEP BRAIN STIMULATI
[6]  
[Anonymous], 2011, Cochrane
[7]  
[Anonymous], J ECT
[8]   Use of pharmacologic coma for adult status epilepticus [J].
Anschel, DJ ;
Fink, M .
EPILEPSY & BEHAVIOR, 2005, 6 (02) :292-292
[9]   Aggravation of seizures and status epilepticus after vagal nerve stimulation therapy: the first pediatric case and review of the literature [J].
Arhan, Ebru ;
Serdaroglu, Ayse ;
Hirfanoglu, Tugba ;
Kurt, Gokhan .
CHILDS NERVOUS SYSTEM, 2018, 34 (09) :1799-1801
[10]  
Aroor S, 2017, J CLIN DIAGN RES, V11, pSR1, DOI 10.7860/JCDR/2017/25811.10485